Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-14 4:34 pm Purchase |
2023-04-04 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 12,302,237 6.500% |
12,302,237 (New Position) |
Filing History |
| 2023-02-09 4:01 pm Sale |
2022-12-31 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO/CA/ | 15,659,053 8.330% |
-1,753,369 (-10.07%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 23,065,775 12.270% |
4,553,864 (+24.60%) |
Filing History |
| 2023-02-06 3:02 pm Sale |
2022-12-30 | 13G | Nektar Therapeutics NKTR |
Wellington Management Group LLP | 0 0.000% |
-11,383,721 (Position Closed) |
Filing History |
| 2023-02-02 3:19 pm Purchase |
2023-02-02 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
37,327,473 19.900% |
435,979 (+1.18%) |
Filing History |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
35,928,093 19.100% |
9,256,290 (+34.70%) |
Filing History |
| 2022-02-11 12:22 pm Purchase |
2022-02-11 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
36,891,494 20.000% |
1,434,545 (+4.05%) |
Filing History |
| 2022-02-10 12:26 pm Sale |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO/CA/ | 17,412,422 9.430% |
-1,027,977 (-5.57%) |
Filing History |
| 2022-02-09 09:22 am Sale |
2022-02-08 | 13G | Nektar Therapeutics NKTR |
FMR LLC | 6,759,203 3.662% |
-2,706,605 (-28.59%) |
Filing History |
| 2022-02-04 09:29 am Sale |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
Wellington Management Group LLP | 11,383,721 6.170% |
-2,008,891 (-15.00%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
26,671,803 14.500% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
26,671,803 14.500% |
8,293,723 (+45.13%) |
Filing History |
| 2022-01-10 11:49 am Purchase |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 18,511,911 10.030% |
2,239,326 (+13.76%) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | Nektar Therapeutics NKTR |
FMR LLC | 9,465,808 5.128% |
-9,483,876 (-50.05%) |
Filing History |
| 2021-02-12 2:53 pm Purchase |
2021-02-12 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
35,456,949 19.800% |
3,827,815 (+12.10%) |
Filing History |
| 2021-02-12 12:02 pm Sale |
2009-02-28 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO/CA/ | 18,440,399 10.280% |
-1,639,949 (-8.17%) |
Filing History |
| 2021-02-10 11:28 am Purchase |
2020-12-31 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 16,272,585 9.070% |
114,974 (+0.71%) |
Filing History |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | Nektar Therapeutics NKTR |
FMR LLC | 18,949,684 10.562% |
251,281 (+1.34%) |
Filing History |
| 2021-02-04 11:31 am Sale |
2020-12-31 | 13G | Nektar Therapeutics NKTR |
Wellington Management Group LLP | 13,392,612 7.470% |
-2,805,567 (-17.32%) |
Filing History |
| 2021-01-26 6:52 pm Sale |
2020-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
18,378,080 10.200% |
-39,455 (-0.21%) |
Filing History |